{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T02:21:03Z","timestamp":1793586063757,"version":"4.5.0"},"reference-count":140,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003448","name":"General Secretariat for Research and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003448","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.jaut.2019.102327","type":"journal-article","created":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T00:42:03Z","timestamp":1566952923000},"page":"102327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":109,"special_numbering":"C","title":["Autotaxin and chronic inflammatory diseases"],"prefix":"10.1016","volume":"104","author":[{"given":"Christiana","family":"Magkrioti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apostolos","family":"Galaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paraskevi","family":"Kanellopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elli-Anna","family":"Stylianaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanna","family":"Kaffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilis","family":"Aidinis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2019.102327_bib1","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1016\/S0021-9258(18)45911-X","article-title":"Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein","volume":"267","author":"Stracke","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jaut.2019.102327_bib2","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1016\/j.febslet.2014.02.009","article-title":"Autotaxin in the crosshairs: taking aim at cancer and other inflammatory conditions","volume":"588","author":"Benesch","year":"2014","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jaut.2019.102327_bib3","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.plipres.2015.02.001","article-title":"Autotaxin, a secreted lysophospholipase D, as a promising therapeutic target in chronic inflammation and cancer","volume":"58","author":"Barbayianni","year":"2015","journal-title":"Prog. Lipid Res."},{"issue":"2","key":"10.1016\/j.jaut.2019.102327_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2014.11.010","article-title":"New insights in the autotaxin\/LPA axis in cancer development and metastasis","volume":"333","author":"Leblanc","year":"2014","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.jaut.2019.102327_bib5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1194\/jlr.R060020","article-title":"a lysophospholipase D with pleomorphic effects in oncogenesis and cancer progression","volume":"57","author":"Federico","year":"2016","journal-title":"JLR (J. Lipid Res.)"},{"key":"10.1016\/j.jaut.2019.102327_bib6","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bbalip.2012.08.015","article-title":"Role of the autotaxin-lysophosphatidate axis in cancer resistance to chemotherapy and radiotherapy","volume":"1831","author":"Brindley","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jaut.2019.102327_bib7","doi-asserted-by":"crossref","first-page":"43543","DOI":"10.18632\/oncotarget.16672","article-title":"Lysophosphatidic acid (LPA) as a pro-fibrotic and pro-oncogenic factor: a pivotal target to improve the radiotherapy therapeutic index","volume":"8","author":"Rancoule","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.jaut.2019.102327_bib8","article-title":"Autotaxin in embryonic development","volume":"1831","author":"Moolenaar","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jaut.2019.102327_bib9","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1242\/dev.121723","article-title":"Lysophosphatidic acid signalling in development","volume":"142","author":"Sheng","year":"2015","journal-title":"Development"},{"key":"10.1016\/j.jaut.2019.102327_bib10","first-page":"130","article-title":"Lysophosphatidic acid-induced YAP\/TAZ activation promotes developmental angiogenesis by repressing Notch ligand Dll4","author":"Yasuda","year":"2019","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.jaut.2019.102327_bib11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3389\/fnins.2015.00053","article-title":"Non-cell autonomous and non-catalytic activities of ATX in the developing brain","volume":"9","author":"Greenman","year":"2015","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.jaut.2019.102327_bib12","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.bbalip.2008.04.009","article-title":"A multi-functional and multi-modular protein possessing enzymatic lysoPLD activity and matricellular properties","volume":"1781","author":"Yuelling","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jaut.2019.102327_bib13","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/jnr.20686","article-title":"Phosphodiesterase-Ialpha\/autotaxin (PD-Ialpha\/ATX): a multifunctional protein involved in central nervous system development and disease","volume":"82","author":"Dennis","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jaut.2019.102327_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126734","article-title":"Autotaxin overexpression causes embryonic lethality and vascular defects","volume":"10","author":"Yukiura","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2019.102327_bib15","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/aji.12239","article-title":"Emerging roles for lysophospholipid mediators in pregnancy","volume":"72","author":"Nagamatsu","year":"2014","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jaut.2019.102327_bib16","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/humupd\/dmn023","article-title":"Lysophospholipid signaling in the function and pathology of the reproductive system","volume":"14","author":"Ye","year":"2008","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.jaut.2019.102327_bib17","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bbalip.2012.07.019","article-title":"Lysoglycerophospholipids in chronic inflammatory disorders: the PLA(2)\/LPC and ATX\/LPA axes","volume":"1831","author":"Sevastou","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jaut.2019.102327_bib18","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/hep.28973","article-title":"Hepatocyte autotaxin expression promotes liver fibrosis and cancer","volume":"65","author":"Kaffe","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2019.102327_bib19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3390\/cancers10030073","article-title":"Coming of age for autotaxin and lysophosphatidate signaling: clinical applications for preventing, detecting and targeting tumor-promoting inflammation","volume":"10","author":"Benesch","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.jaut.2019.102327_bib20","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1194\/jlr.M014985","article-title":"Adipose-specific disruption of autotaxin enhances nutritional fattening and reduces plasma lysophosphatidic acid","volume":"52","author":"Dusaulcy","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jaut.2019.102327_bib21","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.2337\/db13-1694","article-title":"ENPP2 contributes to adipose tissue expansion and insulin resistance in diet-induced obesity","volume":"63","author":"Nishimura","year":"2014","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.jaut.2019.102327_bib22","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1194\/jlr.R046391","article-title":"structure-function and signaling","volume":"55","author":"Perrakis","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jaut.2019.102327_bib23","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nsmb.1980","article-title":"Structural basis of substrate discrimination and integrin binding by autotaxin","volume":"18","author":"Hausmann","year":"2011","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jaut.2019.102327_bib24","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nsmb.1998","article-title":"Crystal structure of autotaxin and insight into GPCR activation by lipid mediators","volume":"18","author":"Nishimasu","year":"2011","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jaut.2019.102327_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/nrm3188","article-title":"Insights into autotaxin: how to produce and present a lipid mediator","volume":"12","author":"Moolenaar","year":"2011","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jaut.2019.102327_bib26","doi-asserted-by":"crossref","first-page":"39436","DOI":"10.1074\/jbc.M205623200","article-title":"Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase","volume":"277","author":"Tokumura","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jaut.2019.102327_bib27","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.tibs.2005.08.005","article-title":"NPP-type ectophosphodiesterases: unity in diversity","volume":"30","author":"Stefan","year":"2005","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.jaut.2019.102327_bib28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/jb\/mvu077","article-title":"Lysophosphatidic acid as a lipid mediator with multiple biological actions","volume":"157","author":"Aikawa","year":"2015","journal-title":"J. Biochem."},{"key":"10.1016\/j.jaut.2019.102327_bib29","doi-asserted-by":"crossref","first-page":"272","DOI":"10.7555\/JBR.30.20150058","article-title":"Recent advances in targeting the autotaxin-lysophosphatidate-lipid phosphate phosphatase axis in vivo","volume":"30","author":"Benesch","year":"2016","journal-title":"J Biomed Res"},{"key":"10.1016\/j.jaut.2019.102327_bib30","doi-asserted-by":"crossref","first-page":"34654","DOI":"10.1074\/jbc.M111.276725","article-title":"Binding of autotaxin to integrins localizes lysophosphatidic acid production to platelets and mammalian cells","volume":"286","author":"Fulkerson","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jaut.2019.102327_bib31","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1182\/blood-2014-04-568683","article-title":"Interaction of platelet-derived autotaxin with tumor integrin alphaVbeta3 controls metastasis of breast cancer cells to bone","volume":"124","author":"Leblanc","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jaut.2019.102327_bib32","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bbalip.2012.07.019","article-title":"Lysoglycerophospholipids in chronic inflammatory disorders: the PLA(2)\/LPC and ATX\/LPA axes","volume":"1831","author":"Sevastou","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jaut.2019.102327_bib33","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/nrm2299","article-title":"Heterotrimeric G protein activation by G-protein-coupled receptors","volume":"9","author":"Oldham","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jaut.2019.102327_bib34","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1194\/jlr.R046458","article-title":"LPA receptor signaling: pharmacology, physiology, and pathophysiology","volume":"55","author":"Yung","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jaut.2019.102327_bib35","first-page":"582","article-title":"The emerging role of lysophosphatidic acid in cancer","volume":"3","author":"Mills","year":"2003","journal-title":"Nature reviews"},{"key":"10.1016\/j.jaut.2019.102327_bib36","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3390\/ijms17020215","article-title":"G-Protein-Coupled lysophosphatidic acid receptors and their regulation of AKT signaling","volume":"17","author":"Riaz","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jaut.2019.102327_bib37","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/sj.onc.1204187","article-title":"Ras-MAP kinase signaling by lysophosphatidic acid and other G protein-coupled receptor agonists","volume":"20","author":"Kranenburg","year":"2001","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.jaut.2019.102327_bib38","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.bbalip.2012.09.004","article-title":"Lysophospholipid receptor activation of RhoA and lipid signaling pathways","volume":"1831","author":"Xiang","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jaut.2019.102327_bib39","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.yexcr.2014.11.012","article-title":"Lysophosphatidic acid contributes to angiogenic homeostasis","volume":"333","author":"Kazlauskas","year":"2015","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.jaut.2019.102327_bib40","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.yexcr.2015.03.016","article-title":"Lysophospholipid mediators in the vasculature","volume":"333","author":"Mueller","year":"2015","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.jaut.2019.102327_bib41","series-title":"Platelets, Autotaxin and Lysophosphatidic Acid Signaling: Win-Win Factors for Cancer Metastasis","author":"Leblanc","year":"2018"},{"key":"10.1016\/j.jaut.2019.102327_bib42","doi-asserted-by":"crossref","first-page":"851","DOI":"10.4049\/jimmunol.1302831","article-title":"The autotaxin-LPA Axis emerges as a novel regulator of lymphocyte homing and inflammation","volume":"192","author":"Knowlden","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2019.102327_bib43","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1194\/jlr.M008045","article-title":"TNF-alpha promotes LPA1- and LPA3-mediated recruitment of leukocytes in vivo through CXCR2 ligand chemokines","volume":"52","author":"Zhao","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jaut.2019.102327_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.116.237156","article-title":"Selective inhibition of autotaxin is efficacious in mouse models of liver fibrosis","volume":"360","author":"Bain","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jaut.2019.102327_bib45","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bbalip.2012.08.001","article-title":"Lysophosphatidic acid: a potential mediator of osteoblast-osteoclast signaling in bone","volume":"1831","author":"Sims","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jaut.2019.102327_bib46","doi-asserted-by":"crossref","first-page":"106335","DOI":"10.1016\/j.prostaglandins.2019.106335","article-title":"Lysophosphatidic acid: its role in bone cell biology and potential for use in bone regeneration","volume":"143","author":"Wu","year":"2019","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.jaut.2019.102327_bib47","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.intimp.2011.09.011","article-title":"Effects of taurochenodeoxycholic acid on adjuvant arthritis in rats","volume":"11","author":"Liu","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jaut.2019.102327_bib48","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1476-5381.2012.02021.x","article-title":"Lysophosphatidic acid in atherosclerotic diseases","volume":"167","author":"Schober","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jaut.2019.102327_bib49","doi-asserted-by":"crossref","first-page":"77","DOI":"10.5320\/wjr.v3.i3.77","article-title":"ATX and LPA signalling in lung pathophysiology","volume":"3","author":"Magkrioti","year":"2013","journal-title":"World J. Respirol."},{"issue":"3","key":"10.1016\/j.jaut.2019.102327_bib50","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1476-5381.2012.02021.x","article-title":"Lysophosphatidic acid in atherosclerotic diseases","volume":"167","author":"Schober","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jaut.2019.102327_bib51","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/j.celrep.2017.07.080","article-title":"Lysophosphatidic acid receptor 4 activation augments drug delivery in tumors by tightening endothelial cell-cell contact","volume":"20","author":"Takara","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.jaut.2019.102327_bib52","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1549-8719.2010.00001.x","article-title":"Regulation of cerebromicrovascular permeability by lysophosphatidic acid","volume":"17","author":"Sarker","year":"2010","journal-title":"Microcirculation"},{"key":"10.1016\/j.jaut.2019.102327_bib53","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nm1685","article-title":"The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak","volume":"14","author":"Tager","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2019.102327_bib54","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/ni1573","article-title":"Autotaxin, an ectoenzyme that produces lysophosphatidic acid, promotes the entry of lymphocytes into secondary lymphoid organs","volume":"9","author":"Kanda","year":"2008","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.jaut.2019.102327_bib55","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.4049\/jimmunol.1202025","article-title":"Constitutive lymphocyte transmigration across the basal lamina of high endothelial venules is regulated by the autotaxin\/lysophosphatidic acid Axis","volume":"190","author":"Bai","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2019.102327_bib56","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.10561","article-title":"Fibroblastic reticular cell-derived lysophosphatidic acid regulates confined intranodal T-cell motility","volume":"5","author":"Takeda","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.jaut.2019.102327_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101655","article-title":"Regulation of T Cell motility in vitro and in vivo by LPA and LPA2","volume":"9","author":"Knowlden","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jaut.2019.102327_bib58","doi-asserted-by":"crossref","first-page":"617","DOI":"10.4049\/jimmunol.1400565","article-title":"Autotaxin produced by stromal cells promotes LFA-1-independent and rho-dependent interstitial T cell motility in the lymph node paracortex","volume":"193","author":"Katakai","year":"2014","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.jaut.2019.102327_bib59","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/intimm\/dxv072","article-title":"Lysophosphatidic acid receptors LPA4 and LPA6 differentially promote lymphocyte transmigration across high endothelial venules in lymph nodes","volume":"28","author":"Hata","year":"2015","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jaut.2019.102327_bib60","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41574-019-0165-y","article-title":"Molecular pathways linking adipose innervation to insulin action in obesity and diabetes mellitus","volume":"15","author":"Guilherme","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.jaut.2019.102327_bib61","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1210\/me.2011-1229","article-title":"Autotaxin and its product lysophosphatidic acid suppress brown adipose differentiation and promote diet-induced obesity in mice","volume":"26","author":"Federico","year":"2012","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jaut.2019.102327_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208099","article-title":"Adipose-derived autotaxin regulates inflammation and steatosis associated with diet-induced obesity","volume":"14","author":"Brandon","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2019.102327_bib63","article-title":"Lysophosphatidic acid signaling in obesity and insulin resistance","volume":"10","author":"D'Souza","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.jaut.2019.102327_bib64","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1194\/jlr.M082008","article-title":"Autotaxin-LPA signaling contributes to obesity-induced insulin resistance in muscle and impairs mitochondrial metabolism","volume":"59","author":"D'Souza","year":"2018","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jaut.2019.102327_bib65","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1161\/ATVBAHA.113.302737","article-title":"Arguing the case for the autotaxin-lysophosphatidic acid-lipid phosphate phosphatase 3-signaling nexus in the development and complications of atherosclerosis","volume":"34","author":"Smyth","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jaut.2019.102327_bib66","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/MOL.0000000000000226","article-title":"Lysophospholipids in coronary artery and chronic ischemic heart disease","volume":"26","author":"Abdel-Latif","year":"2015","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.jaut.2019.102327_bib67","doi-asserted-by":"crossref","first-page":"7385","DOI":"10.1074\/jbc.M807820200","article-title":"Autotaxin\/lysopholipase D and lysophosphatidic acid regulate murine hemostasis and thrombosis","volume":"284","author":"Pamuklar","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jaut.2019.102327_bib68","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/CIRCULATIONAHA.115.016757","article-title":"Autotaxin derived from lipoprotein(a) and valve interstitial cells promotes inflammation and mineralization of the aortic valve","volume":"132","author":"Bouchareb","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jaut.2019.102327_bib69","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/jcmm.14005","article-title":"Autotaxin\/lysophosphatidic acid signaling mediates obesity-related cardiomyopathy in mice and human subjects","volume":"23","author":"Weng","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.jaut.2019.102327_bib70","doi-asserted-by":"crossref","DOI":"10.1530\/JME-18-0242","article-title":"Adipose tissue-derived autotaxin causes cardiomyopathy in obese mice","author":"Xu","year":"2019","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.jaut.2019.102327_bib71","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.2353\/ajpath.2010.090009","article-title":"Atherosclerotic lesion progression changes lysophosphatidic acid homeostasis to favor its accumulation","volume":"176","author":"Bot","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jaut.2019.102327_bib72","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.cmet.2011.02.016","article-title":"Lipoprotein-derived lysophosphatidic acid promotes atherosclerosis by releasing CXCL1 from the endothelium","volume":"13","author":"Zhou","year":"2011","journal-title":"Cell Metabol."},{"key":"10.1016\/j.jaut.2019.102327_bib73","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.prostaglandins.2008.05.002","article-title":"Lysophosphatidic acid-induced oxidized low-density lipoprotein uptake is class A scavenger receptor-dependent in macrophages","volume":"87","author":"Chang","year":"2008","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.jaut.2019.102327_bib74","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3389\/fphys.2017.00266","article-title":"Lysophosphatidic acid is associated with atherosclerotic plaque instability by regulating NF-kappaB dependent matrix metalloproteinase-9 expression via LPA2 in macrophages","volume":"8","author":"Gu","year":"2017","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.jaut.2019.102327_bib75","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bbalip.2012.06.014","article-title":"Lysophosphatidic acid (LPA) and its receptors: role in airway inflammation and remodeling","volume":"1831","author":"Zhao","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jaut.2019.102327_bib76","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1172\/JCI88896","article-title":"Autocrine lysophosphatidic acid signaling activates beta-catenin and promotes lung allograft fibrosis","volume":"127","author":"Cao","year":"2017","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.jaut.2019.102327_bib77","doi-asserted-by":"crossref","first-page":"17074","DOI":"10.1038\/nrdp.2017.74","article-title":"Idiopathic pulmonary fibrosis","volume":"3","author":"Martinez","year":"2017","journal-title":"Nature reviews Disease primers"},{"key":"10.1016\/j.jaut.2019.102327_bib78","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm.2807","article-title":"Mechanisms of fibrosis: therapeutic translation for fibrotic disease","volume":"18","author":"Wynn","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2019.102327_bib79","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0140-6736(11)60405-4","article-title":"Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials","volume":"377","author":"Noble","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2019.102327_bib80","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2019.102327_bib81","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1165\/rcmb.2012-0004OC","article-title":"Pulmonary autotaxin expression contributes to the pathogenesis of pulmonary fibrosis","volume":"47","author":"Oikonomou","year":"2012","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.jaut.2019.102327_bib82","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1096\/fj.201500197R","article-title":"Autotaxin activity increases locally following lung injury, but is not required for pulmonary lysophosphatidic acid production or fibrosis","volume":"30","author":"Black","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.jaut.2019.102327_bib83","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/MCP.0b013e328349ac2b","article-title":"Modeling pulmonary fibrosis with bleomycin","volume":"17","author":"Mouratis","year":"2011","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.jaut.2019.102327_bib84","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3389\/fmed.2018.00269","article-title":"Bleomycin revisited: a direct comparison of the intratracheal micro-spraying and the oropharyngeal aspiration routes of bleomycin administration in mice","volume":"5","author":"Barbayianni","year":"2018","journal-title":"Front. Med."},{"key":"10.1016\/j.jaut.2019.102327_bib85","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1165\/rcmb.2013-0070OC","article-title":"Lysophosphatidic acid receptor-2 deficiency confers protection against bleomycin-induced lung injury and fibrosis in mice","volume":"49","author":"Huang","year":"2013","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.jaut.2019.102327_bib86","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1513\/pats.201101-007MW","article-title":"Pulmonary microcirculation in interstitial lung disease","volume":"8","author":"Farkas","year":"2011","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.jaut.2019.102327_bib87","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1165\/rcmb.2015-0152OC","article-title":"Lysophosphatidic acid signaling through the lysophosphatidic acid-1 receptor is required for alveolarization","volume":"55","author":"Funke","year":"2016","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.jaut.2019.102327_bib88","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1165\/rcmb.2010-0155OC","article-title":"The lysophosphatidic acid receptor LPA1 promotes epithelial cell apoptosis after lung injury","volume":"46","author":"Funke","year":"2012","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.jaut.2019.102327_bib89","doi-asserted-by":"crossref","first-page":"41085","DOI":"10.1074\/jbc.M404045200","article-title":"Protein kinase Cdelta mediates lysophosphatidic acid-induced NF-kappaB activation and interleukin-8 secretion in human bronchial epithelial cells","volume":"279","author":"Cummings","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jaut.2019.102327_bib90","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1042\/BJ20050791","article-title":"Transcriptional regulation of lysophosphatidic acid-induced interleukin-8 expression and secretion by p38 MAPK and JNK in human bronchial epithelial cells","volume":"393","author":"Saatian","year":"2006","journal-title":"Biochem. J."},{"key":"10.1016\/j.jaut.2019.102327_bib91","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1513\/pats.201203-023AW","article-title":"The impact of TGF-beta on lung fibrosis: from targeting to biomarkers","volume":"9","author":"Fernandez","year":"2012","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.jaut.2019.102327_bib92","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.2353\/ajpath.2009.080160","article-title":"Lysophosphatidic acid induces alphavbeta6 integrin-mediated TGF-beta activation via the LPA2 receptor and the small G protein G alpha(q)","volume":"174","author":"Xu","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jaut.2019.102327_bib93","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0092-8674(00)80545-0","article-title":"The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis","volume":"96","author":"Munger","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2019.102327_bib94","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.molmed.2016.02.004","article-title":"Pulmonary macrophages: a new therapeutic pathway in fibrosing lung disease?","volume":"22","author":"Byrne","year":"2016","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jaut.2019.102327_bib95","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fmed.2018.00043","article-title":"The role of immune and inflammatory cells in idiopathic pulmonary fibrosis","volume":"5","author":"Desai","year":"2018","journal-title":"Front. Med."},{"key":"10.1016\/j.jaut.2019.102327_bib96","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nri.2017.125","article-title":"Microglia and macrophages in brain homeostasis and disease","volume":"18","author":"Li","year":"2017","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.jaut.2019.102327_bib97","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1182\/blood-2016-10-743757","article-title":"Lysophosphatidic acid converts monocytes into macrophages in both mice and humans","volume":"129","author":"Ray","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2019.102327_bib98","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2019.102327_bib99","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nrd4592","article-title":"Dissecting fibrosis: therapeutic insights from the small-molecule toolbox","volume":"14","author":"Nanthakumar","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jaut.2019.102327_bib100","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.cca.2011.03.014","article-title":"Autotaxin as a novel serum marker of liver fibrosis","volume":"412","author":"Nakagawa","year":"2011","journal-title":"Clinica chimica acta; international journal of clinical chemistry"},{"key":"10.1016\/j.jaut.2019.102327_bib101","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/oby.20960","article-title":"Serum autotaxin is independently associated with hepatic steatosis in women with severe obesity","volume":"23","author":"Rachakonda","year":"2015","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.jaut.2019.102327_bib102","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1002\/oby.21232","article-title":"Serum Autotaxin\/ENPP2 correlates with insulin resistance in older humans with obesity","volume":"23","author":"Reeves","year":"2015","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.jaut.2019.102327_bib103","doi-asserted-by":"crossref","first-page":"30847","DOI":"10.1038\/srep30847","article-title":"Serum autotaxin is a marker of the severity of liver injury and overall survival in patients with cholestatic liver diseases","volume":"6","author":"Wunsch","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jaut.2019.102327_bib104","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103532","article-title":"Serum autotaxin is a parameter for the severity of liver cirrhosis and overall survival in patients with liver cirrhosis-a prospective cohort study","volume":"9","author":"Pleli","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2019.102327_bib105","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/j.cca.2012.07.014","article-title":"Autotaxin in liver fibrosis","volume":"413","author":"Ikeda","year":"2012","journal-title":"Clinica chimica acta; international journal of clinical chemistry"},{"key":"10.1016\/j.jaut.2019.102327_bib106","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.autrev.2016.03.019","article-title":"Autotaxin, pruritus and primary biliary cholangitis (PBC)","volume":"15","author":"Sun","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2019.102327_bib107","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.canlet.2009.04.029","article-title":"Rapid clearance of the circulating metastatic factor autotaxin by the scavenger receptors of liver sinusoidal endothelial cells","volume":"284","author":"Jansen","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jaut.2019.102327_bib108","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jhep.2017.01.009","article-title":"Autotaxin-lysophosphatidic acid receptor signalling regulates hepatitis C virus replication","volume":"66","author":"Farquhar","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2019.102327_bib109","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/infdis\/jiw372","article-title":"During hepatitis C virus (HCV) infection and HCV-HIV coinfection, an elevated plasma level of autotaxin is associated with lysophosphatidic acid and markers of immune activation that normalize during interferon-free HCV therapy","volume":"214","author":"Kostadinova","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jaut.2019.102327_bib110","doi-asserted-by":"crossref","first-page":"7385","DOI":"10.1074\/jbc.M807820200","article-title":"Autotaxin\/lysopholipase D and lysophosphatidic acid regulate murine hemostasis and thrombosis","volume":"284","author":"Pamuklar","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jaut.2019.102327_bib111","doi-asserted-by":"crossref","first-page":"11248","DOI":"10.1038\/ncomms11248","article-title":"Steroid binding to Autotaxin links bile salts and lysophosphatidic acid signalling","volume":"7","author":"Keune","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jaut.2019.102327_bib112","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2019.102327_bib113","doi-asserted-by":"crossref","first-page":"18001","DOI":"10.1038\/nrdp.2018.1","article-title":"Rheumatoid arthritis","volume":"4","author":"Smolen","year":"2018","journal-title":"Nature Reviews Disease Primers"},{"key":"10.1016\/j.jaut.2019.102327_bib114","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1371\/journal.pgen.0010048","article-title":"Cytoskeletal rearrangements in synovial fibroblasts as a novel pathophysiological determinant of modeled rheumatoid arthritis","volume":"1","author":"Aidinis","year":"2005","journal-title":"PLoS Genet."},{"key":"10.1016\/j.jaut.2019.102327_bib115","doi-asserted-by":"crossref","DOI":"10.1124\/mol.107.038216","article-title":"Regulation of lysophosphatidic acid receptor expression and function in human synoviocytes: implications for rheumatoid arthritis?","volume":"73","author":"Zhao","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jaut.2019.102327_bib116","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1084\/jem.20112012","article-title":"Autotaxin expression from synovial fibroblasts is essential for the pathogenesis of modeled arthritis","volume":"209","author":"Nikitopoulou","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2019.102327_bib117","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1002\/art.37991","article-title":"Necessity of lysophosphatidic acid receptor 1 for development of arthritis","volume":"65","author":"Miyabe","year":"2013","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.jaut.2019.102327_bib118","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1002\/art.34443","article-title":"Lysophosphatidic acid receptor 1 suppression sensitizes rheumatoid fibroblast-like synoviocytes to TNF-induced apoptosis","volume":"64","author":"Orosa","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2019.102327_bib119","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1136\/annrheumdis-2012-202832","article-title":"Lysophosphatidic acid receptor inhibition as a new multipronged treatment for rheumatoid arthritis","volume":"73","author":"Orosa","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2019.102327_bib120","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1476-4598-9-71","article-title":"Autotaxin expression and its connection with the TNF-alpha-NF-kappaB axis in human hepatocellular carcinoma","volume":"9","author":"Wu","year":"2010","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jaut.2019.102327_bib121","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1002\/j.1460-2075.1991.tb04978.x","article-title":"Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis","volume":"10","author":"Keffer","year":"1991","journal-title":"EMBO J."},{"key":"10.1016\/j.jaut.2019.102327_bib122","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.joca.2014.11.012","article-title":"Lysophosphatidic acid mediates fibrosis in injured joints by regulating collagen type I biosynthesis","volume":"23","author":"Wu","year":"2015","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.jaut.2019.102327_bib123","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1186\/s13075-014-0461-9","article-title":"Activation of fibroblast-like synoviocytes derived from rheumatoid arthritis via lysophosphatidic acid-lysophosphatidic acid receptor 1 cascade","volume":"16","author":"Miyabe","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2019.102327_bib124","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.bcp.2014.04.012","article-title":"Lysophosphatidic acid-induced IL-8 secretion involves MSK1 and MSK2 mediated activation of CREB1 in human fibroblast-like synoviocytes","volume":"90","author":"Zhao","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jaut.2019.102327_bib125","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3389\/fphar.2017.00848","article-title":"Differential effects of inhibitor combinations on lysophosphatidic acid-mediated chemokine secretion in unprimed and tumor necrosis factor-alpha-primed synovial fibroblasts","volume":"8","author":"Hui","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jaut.2019.102327_bib126","doi-asserted-by":"crossref","first-page":"248492","DOI":"10.1155\/2015\/248492","article-title":"LPA promotes T cell recruitment through synthesis of CXCL13","volume":"2015","author":"Hui","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.jaut.2019.102327_bib127","series-title":"Osteoclast-derived Autotaxin, a Distinguishing Factor for Inflammatory Bone Loss","author":"Flammier","year":"2019"},{"key":"10.1016\/j.jaut.2019.102327_bib128","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.joca.2016.09.006","article-title":"Identification and pharmacological characterization of a novel inhibitor of autotaxin in rodent models of joint pain","volume":"25","author":"Thirunavukkarasu","year":"2017","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.jaut.2019.102327_bib129","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1152\/physiolgenomics.00070.2017","article-title":"Role of lysophosphatidic acid and its receptors in the kidney","volume":"49","author":"Park","year":"2017","journal-title":"Physiol. Genom."},{"key":"10.1016\/j.jaut.2019.102327_bib130","volume":"vol. 20","author":"Lee","year":"2019"},{"key":"10.1016\/j.jaut.2019.102327_bib131","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19071827","article-title":"Autotaxin(-)Lysophosphatidic acid signaling in alzheimer's disease","volume":"19","author":"Ramesh","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jaut.2019.102327_bib132","series-title":"Lysophosphatidic Acid and Autotaxin-Associated Effects on the Initiation and Progression of Colorectal Cancer","first-page":"11","author":"Yun","year":"2019"},{"issue":"3","key":"10.1016\/j.jaut.2019.102327_bib133","doi-asserted-by":"crossref","DOI":"10.1002\/med.21551","article-title":"Development and therapeutic potential of autotaxin small molecule inhibitors: from bench to advanced clinical trials","volume":"39","author":"Matralis","year":"2018","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jaut.2019.102327_bib134","doi-asserted-by":"crossref","first-page":"5604","DOI":"10.1021\/acs.jmedchem.5b01599","article-title":"Development of autotaxin inhibitors: an overview of the patent and primary literature","volume":"59","author":"Castagna","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jaut.2019.102327_bib135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143083","article-title":"The bulk of autotaxin activity is dispensable for adult mouse life","volume":"10","author":"Katsifa","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2019.102327_bib136","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1021\/acs.jmedchem.7b00032","volume":"60","author":"Desroy","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jaut.2019.102327_bib137","doi-asserted-by":"crossref","DOI":"10.1002\/jcph.1424","article-title":"Safety, pharmacokinetics, and pharmacodynamics of the autotaxin inhibitor GLPG1690 in healthy subjects: phase 1 randomized trials","author":"van der Aar","year":"2019","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jaut.2019.102327_bib138","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S2213-2600(18)30181-4","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised placebo-controlled trial","volume":"6","author":"Maher","year":"2018","journal-title":"The Lancet Respiratory medicine"},{"key":"10.1016\/j.jaut.2019.102327_bib139","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2019-000422","article-title":"Rationale, design and objectives of two phase III, randomised, placebo-controlled studies of GLPG1690, a novel autotaxin inhibitor, in idiopathic pulmonary fibrosis (ISABELA 1 and 2)","volume":"6","author":"Maher","year":"2019","journal-title":"BMJ open respiratory research"},{"issue":"7","key":"10.1016\/j.jaut.2019.102327_bib140","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20181895","article-title":"Lysolipid receptor cross-talk regulates lymphatic endothelial junctions in lymph nodes","volume":"216","author":"Hisano","year":"2019","journal-title":"J. Exp. Med."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841119305505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841119305505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:24:46Z","timestamp":1760257486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841119305505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":140,"alternative-id":["S0896841119305505"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2019.102327","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autotaxin and chronic inflammatory diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2019.102327","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102327"}}